US pharmaceutical sector continued to rise, AstraZeneca up over 6% after earnings

Odaily reports: According to MSX.COM data, the US pharmaceutical sector continued to rise, with AstraZeneca up over 6% after earnings as Q3 profit beat expectations; Eli Lilly and Gilead Sciences up over 4%, Amgen up nearly 3%, and Johnson & Johnson up nearly 2%, with intraday share prices all hitting record highs.